Personalis, Inc. Profile Avatar - Palmy Investing

Personalis, Inc.

Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides…

Medical - Diagnostics & Research
US, Menlo Park [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Personalis, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of PSNL's Analysis
CIK: 1527753 CUSIP: 71535D106 ISIN: US71535D1063 LEI: - UEI: -
Secondary Listings
PSNL has no secondary listings inside our databases.